Solventum Corporation

NYSE SOLV

Solventum Corporation EBIT for the Trailing 12 Months (TTM) ending September 30, 2024: USD 1.25 B

Solventum Corporation EBIT is USD 1.25 B for the Trailing 12 Months (TTM) ending September 30, 2024, a -19.78% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • Solventum Corporation EBIT for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 1.56 B.
Key data
Date EBIT EBITDA Net Income EPS (Diluted)
Market news
Loading...
NYSE: SOLV

Solventum Corporation

CEO Mr. Bryan C. Hanson
IPO Date April 1, 2024
Location United States
Headquarters 3M Center
Employees 22,000
Sector Health Care
Industries
Description

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

StockViz Staff

January 15, 2025

Any question? Send us an email